Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Cash flows from operating activities:
Net income	$ 209,700	$ 320,200
Depreciation and amortization	275,000	257,100
Settlement of contingent consideration	0	(40,700)
Change in fair value of contingent consideration	(31,800)	(10,700)
Accrual for acquisition termination fee	45,000	0
Net changes in operating capital	(188,800)	(8,700)
Other non-cash items	124,200	44,500
Net cash provided by operating activities	433,300	561,700
Cash flows from investing activities:
Purchases of property, plant and equipment	(247,500)	(147,100)
Acquisitions of businesses and assets, net of cash acquired, and other	(40,700)	(1,636,500)
Proceeds from sale of interest in a subsidiary	0	52,100
Net cash used in investing activities	(288,200)	(1,731,500)
Cash flows from financing activities:
Proceeds from long-term debt, net of issuance costs	1,652,000	1,499,500
Repayments of long-term debt	(1,490,400)	(549,600)
Net (repayments of) proceeds from short-term debt	(335,500)	462,700
Net proceeds (payments) related to share-based compensation awards	2,200	(8,000)
Dividends on common stock	(1,500)	(1,500)
Repurchase of common stock	0	(78,500)
Issuance of common stock for employee stock purchase plan	5,800	5,400
Settlement of contingent consideration	0	(2,200)
Net cash (used in) provided by financing activities	(167,400)	1,327,800
Effect of exchange rate changes on cash, cash equivalents and restricted cash	1,200	(8,000)
Net (decrease) increase in cash, cash equivalents, and restricted cash	(21,100)	150,000
Cash, cash equivalents, and restricted cash at beginning of period	138,600	96,600
Cash, cash equivalents, and restricted cash at end of period	117,500	246,600
Reconciliation of cash flow information:
Cash and cash equivalents	117,300	246,300
Restricted cash included in other current assets	200	300
Total cash, cash equivalents, and restricted cash	$ 117,500	$ 246,600